These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 29123930
1. Chronic Myeloid Leukemia with an e6a2 BCR-ABL1 Fusion Transcript: Cooperating Mutations at Blast Crisis and Molecular Monitoring. Crampe M, Haslam K, Groarke E, Kelleher E, O'Shea D, Conneally E, Langabeer SE. Case Rep Hematol; 2017; 2017():9071702. PubMed ID: 29123930 [Abstract] [Full Text] [Related]
2. Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report. Manzella L, Tirrò E, Vitale SR, Puma A, Consoli ML, Tambè L, Pennisi MS, DI Gregorio S, Romano C, Tomarchio C, DI Raimondo F, Stagno F. In Vivo; 2020; 34(3):1481-1486. PubMed ID: 32354950 [Abstract] [Full Text] [Related]
3. BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR. Zagaria A, Anelli L, Coccaro N, Tota G, Casieri P, Cellamare A, Impera L, Brunetti C, Minervini A, Minervini CF, Delia M, Cumbo C, Orsini P, Specchia G, Albano F. Virchows Arch; 2015 Sep; 467(3):357-63. PubMed ID: 26149409 [Abstract] [Full Text] [Related]
4. Atypical presentation of patients with chronic myeloid leukemia in chronic phase-Case report. Ramdohr F, Fabarius A, Maier B, Bretschneider D, Jauch A, Monecke A, Metzeler KH, Janssen JWG, Schlenk RF, Kayser S. Front Oncol; 2022 Sep; 12():960914. PubMed ID: 36106102 [Abstract] [Full Text] [Related]
5. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review. Piedimonte M, Ottone T, Alfonso V, Ferrari A, Conte E, Divona M, Bianchi MP, Ricciardi MR, Mirabilii S, Licchetta R, Campagna A, Cicconi L, Galassi G, Pelliccia S, Leporace A, Lo Coco F, Tafuri A. BMC Cancer; 2019 Jan 10; 19(1):50. PubMed ID: 30630459 [Abstract] [Full Text] [Related]
10. Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre. Qin YZ, Jiang Q, Jiang H, Lai YY, Shi HX, Chen WM, Yu L, Huang XJ. Br J Haematol; 2018 Sep 10; 182(5):693-700. PubMed ID: 29974949 [Abstract] [Full Text] [Related]
13. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation. Huang T, Fu Y, Wang S, Xu M, Yin X, Zhou M, Wang X, Chen C. Biomed Pharmacother; 2019 Nov 10; 119():109413. PubMed ID: 31518872 [Abstract] [Full Text] [Related]
15. New Developments in Chronic Myeloid Leukemia: Implications for Therapy. Tabarestani S, Movafagh A. Iran J Cancer Prev; 2016 Feb 10; 9(1):e3961. PubMed ID: 27366312 [Abstract] [Full Text] [Related]
16. Extramedullary blast crisis as initial presentation in chronic myeloid leukemia with the e1a2 BCR-ABL1 transcript: A case report. Ai DI, Liu W, Lu G, Patel KP, Chen ZI. Mol Clin Oncol; 2015 Nov 10; 3(6):1319-1322. PubMed ID: 26807241 [Abstract] [Full Text] [Related]